William K. Sonnenburg

Publications by Year

Research Areas

Phosphodiesterase function and regulation, Cholinesterase and Neurodegenerative Diseases, Chemical Synthesis and Analysis, Receptor Mechanisms and Signaling, Diabetes, Cardiovascular Risks, and Lipoproteins

Most-Cited Works

• → Isolation and characterization of cDNAs encoding PDE5A, a human cGMP-binding, cGMP-specific 3′,5′-cyclic nucleotide phosphodiesterase(1998)218 cited
• → Identification of a New Functional Domain in Angiopoietin-like 3 (ANGPTL3) and Angiopoietin-like 4 (ANGPTL4) Involved in Binding and Inhibition of Lipoprotein Lipase (LPL)(2009)164 cited
• → Isolation and Characterization of cDNAs Corresponding to Two Human Calcium, Calmodulin-regulated, 3′,5′-Cyclic Nucleotide Phosphodiesterases(1996)142 cited
• → Isolation and characterization of human cDNAs encoding a cGMP-stimulated 3′,5′-cyclic nucleotide phosphodiesterase(1997)138 cited
• → Identification of Inhibitory and Calmodulin-binding Domains of the PDE1A1 and PDE1A2 Calmodulin-stimulated Cyclic Nucleotide Phosphodiesterases(1995)126 cited
• → GPIHBP1 stabilizes lipoprotein lipase and prevents its inhibition by angiopoietin-like 3 and angiopoietin-like 4(2009)125 cited
• → Inhibition of Sphingosine 1-Phosphate Lyase for the Treatment of Rheumatoid Arthritis: Discovery of (E)-1-(4-((1R,2S,3R)-1,2,3,4-Tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone Oxime (LX2931) and (1R,2S,3R)-1-(2-(Isoxazol-3-yl)-1H-imidazol-4-yl)butane-1,2,3,4-tetraol (LX2932)(2010)110 cited
• → An Essential Aspartic Acid at Each of Two Allosteric cGMP-binding Sites of a cGMP-specific Phosphodiesterase(1995)96 cited
• → Cyclic GMP and Regulation of Cyclic Nucleotide Hydrolysis(1994)74 cited
• → Amino acid sequence of the cyclic GMP stimulated cyclic nucleotide phosphodiesterase from bovine heart(1990)60 cited